Sign up to The Irish Times Archive (1859 - 2008)My Account »

The withdrawal of Roaccutane, the anti-acne drug, in the US has a huge effect on legal cases against its manufacturer here, writes KITTY HOLLAND.

THE WITHDRAWAL last week of the anti-acne drug, Roaccutane, from the US market has “relevance” for up to 10 pending cases here against the drug manufacturer, Roche Pharmaceuticals, according to the main solicitor taking the cases.